Searchable abstracts of presentations at key conferences in endocrinology

ea0065p235 | Metabolism and Obesity | SFEBES2019

Insights into the mechanisms underpinning the physiological effects of biased GLP-1 receptor agonists

Lucey Maria , Pickford Phil , Ma Yue , Shchepinova Maria , Tate Ed , McGinty James , French Paul , Davies Samuel , Xavier Gabriela Da Silva , Stolarczyk Emilie , Minnion James , Rutter Guy , Bloom Steve , Tomas Alejandra , Jones Ben

Glucagon-like peptide-1 receptor (GLP-1R) agonists are effective treatments for type 2 diabetes and obesity. We recently described ‘biased’ peptide GLP-1R agonists modelled on exendin-4 which uncouple the pronounced endocytosis that usually accompanies GLP-1R activation, leading to prolongation of intracellular signalling responses. Here, we show that the metabolic consequences of biased GLP-1R activation in vivo are dominated by improvements in blood glucos...

ea0067o10 | Oral Presentations | EYES2019

The genetic landscape of indeterminate thyroid nodules

Borowczyk Martyna , Szczepanek-Parulska Ewelina , Dębicki Szymon , Budny Bartłomiej , Verburg Frederik A , Filipowicz Dorota , Wrotkowska Elżbieta , Janicka-Jedyńska Małgorzata , Więckowska Barbara , Gil Lidia , Ziemnicka Katarzyna , Ruchała Marek

Objective: The thyroid fine needle aspiration biopsy (FNAB) may bring inconclusive cytological results of atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) or follicular neoplasm/suspicious for follicular neoplasm (FN/SFN). The objective of the study was to describe the genetic landscape of indeterminate thyroid nodules to better understand this phenomenon and identify genetic markers potentially differentiating benign and malignant ...

ea0063p421 | Adrenal and Neuroendocrine Tumours 2 | ECE2019

RET Y791F carriers’ medical history – experience from one center

Hasse-Lazar Kornelia , Kotecka-Blicharz Agnieszka , Oczko-Wojciechowska Małgorzata , Pawlaczek Agnieszka , Michalik Barbara , Gawlik Tomasz , Jurecka-Lubieniecka Beata , Krajewska Jolanta , Krol Aleksandra , Legutko Marta , Czarniecka Agnieszka , Zeman Marcin , Jarzęb Barbara

Introduction: Germline mutations of RET oncogene result in development of multiple endocrine neoplasia type 2 (MEN 2). There is a strong correlation between type of the RET sequence changes and the aggressiveness of main syndrome feature, medullary thyroid carcinoma (MTC), and the incidence of remaining manifestations, mainly pheochromocytoma (PHEO). For many of the RET germline mutations, the clinical risk have been precisely defined, but there are ...

ea0063p746 | Thyroid 2 | ECE2019

External beam radiotherapy in differentiated thyroid cancer: clinical experience in a large spainish multicentre study

Romero-Lluch Ana , Anda Emma , Santamaria Javier , Diez Juan Jose , Donnay Sergio , Galofre Juan Carlos , Menendez Edelmiro , Perez Begona , Sastre Julia , Alcazar Victoria , Blanco Concepcion , Iglesias Pedro , Pamplona Ma Jose , Navarro Elena

The role of adjuvant external beam radiotherapy (EBRT) in differenciated thyroid cancer (DTC) is controversial. It remains unknown whether EBRT in the neck following conventional treatment might improve progression-free survival (PFS) and overall survival (OS).Objective: To assess EBRT outcomes in patients with locally advanced DTC in terms of local disease progression, PFS and OS.Material and Methods: A multicentric retrospective ...

ea0063p1077 | Pituitary and Neuroendocrinology 3 | ECE2019

Long term observation of patients with pituitary stalk lesions – single center experience

Kluczyński Łukasz , Gilis-Januszewska Aleksandra , Rogoziński Damian , Pantofliński Jacek , Żabicka Katarzyna , Zygmunt-Gorska Agata , Wojcik Małgorzata , Starzyk Jerzy , Hubalewska-Dydejczyk Alicja

Background: Pituitary stalk lesions (PSL) are various changes located in the pituitary infundibulum. The underlying pathology and exact diagnosis are difficult to establish due to their difficult anatomical locus.Aim: To present the etiological spectrum of pituitary stalk lesions and their clinical and hormonal characteristics on the basis of long term observation in the pediatric/adult endocrinology departments of our university.M...

ea0063p1204 | Thyroid 3 | ECE2019

TP53 and FLT3 may become candidate markers for detecting malignancy in follicular lesions

Borowczyk Martyna , Szczepanek-Parulska Ewelina , Dębicki Szymon , Budny Bartłomiej , Verburg Frederik A , Janicka-Jedyńska Małgorzata , Więckowska Barbara , Gil Lidia , Filipowicz Dorota , Ziemnicka Katarzyna , Ruchała Marek

Introduction: The aim of the present study was to compare follicular thyroid adenoma (FTA) and follicular thyroid carcinoma (FTC) using the wide oncological molecular panel and identify differences in mutational status which may aid in the preoperative differentiation between these two related thyroidal pathologies, as well as in an understanding their pathways of origin.Material and methods: We analyzed formalin-fixed paraffin-embedded (FFPE) samples ac...

ea0049ep155 | Endocrine tumours and neoplasia | ECE2017

False positive findings on 6-[18F]fluor-L-3,4-dihydroxyphenylalanine Positron Emission Tomography (18F-FDOPA-PET) performed for imaging of neuroendocrine tumors

Berends MA , Bolt JW , Kerstens MN , Links TP , Korpershoek E , de Krijger RR , Walenkamp AME , Noordzij W , van Etten B , Kats-Urgurlu G , Brouwers AH , van der Horst-Schrivers ANA

Background/Aim: Neuroendocrine tumors (NETs) are rare tumors arising from neuroendocrine cells throughout the body. Positron Emission Tomography (PET) scanning with 6-[18F]fluor-L-3,4-dihydroxyphenylalanine (18F-FDOPA) has been shown to be a valuable technique for the imaging of NETs. While the sensitivity has been assessed numerously, studies systematically describing false positive results, other than physiological variants, are lacking. Our aim was to systematica...

ea0041ep807 | Obesity | ECE2016

Changes in SCD1 promoter DNA methylation after bariatric surgery in morbid obese patients are associated with free fatty acids levels

Morcillo Sonsoles , Martin-Nunez Gracia Ma , Garcia-Serrano Sara , Gutierrez-Repiso Carolina , Rodriguez-Pacheco Francisca , Ho-Plagaro Ailec , Alaminos-Castillo Miguel A , Valdes Sergio , Gonzalo Motserrat , Moreno-Ruiz Francisco J. , Montiel-Casado Custodia , Rodriguez-Canete Alberto , Garcia-Fuentes Eduardo

Introduction: Epigenetic is acquiring great importance in complex diseases, providing mechanisms whereby environmental factors can influence complex diseases such as obesity and type 2 diabetes. Experimental animal and human studies have revealed the association between SCD1 and obesity and insulin resistance. The aim of this study was to evaluate whether metabolic changes after intervention are associated with DNA methylation pattern and if these changes are related to weigh ...

ea0059oc3.5 | Obesity & diabetes | SFEBES2018

Hypothalamic arcuate glucokinase and its downstream pathways are critical in glucose homeostasis

Ratnasabapathy Risheka , Ma Yue , Izzi-Engbeaya Chioma , Nguyen-Tu Marie-Sophie , Richardson Errol , Hussain Sufyan , De Backer Ivan , Holton Christopher , Norton Mariana , Carrat Gaelle , Schwappach Blanche , Rutter Guy A , Dhillo Waljit S , Gardiner James V

As the nation gets fatter, the incidence of diabetes is also rising. The brain is now emerging as a critical mediator of blood sugar control, re-directing focus away from the traditional pancreas-centred model. The enzyme glucokinase (GK) acts as a glucose sensor in many tissues including glucose-sensitive neurones within the hypothalamic arcuate nucleus. However, the role of GK here is unclear. We investigated the role of arcuate GK in glucose homeostasis in both healthy and ...

ea0070aep294 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Fibroblast growth factor 21 (FGF21) in hyper- and hypothyroidism, association with metabolic disturbances

Szczepańska Ewa , Gietka-Czernel Małgorzata , Glinicki Piotr , Jastrzębska Helena , Słowińska-Srzednicka Jadwiga , Kapuścińska Renata , Zgliczyński Stefan , Zgliczyński Wojciech

Background: FGF21 is a critical metabolic regulator with beneficial effects on lipid and glucose metabolism. FGF21 is produced primarily by the liver and stimulates fatty acids oxidation, which prevents hepatic triglycerides accumulation and nonalcoholic fatty liver disease (NALFD). FGF21also increases insulin sensitivity and glucose uptake in adipose tissue. Paradoxically FGF21 is elevated in insulin resistance states e.g. NALFD, obesity and type 2 diabetes. It is not determi...